UBS upgraded MCX to Buy from Neutral and raised its target price to Rs 3,800, citing attractive valuations, resilient trading volumes and positive regulatory developments. The brokerage also raised its FY27-FY29 EPS estimates by 4%-9%, while expecting strong commodity volatility and operating leverage to support earnings growth.
India not only has a shortage of caregivers, but also lacks a system to ensure they are properly trained, recognised and available to those who need them.
The Economic and Financial Crimes Commission (EFCC) has been urged to investigate an alleged fraud and impersonation involving a $300 million investment claim in the River Park Estate dispute.